Digital Therapeutics Market Estimated to Experience a Hike in Growth by 2035
Digital therapeutics are designed to engage patients in personalized treatment or disease prevention programs, through mediating behavioral or psychological modifications, providing motivational support and inculcating healthy lifestyle changes.
The global digital therapeutics market size is estimated to grow from USD 2.31 billion in 2023 to USD 19.76 billion by 2035, representing a CAGR of 19.59% during the forecast period 2023-2035.
Digital therapeutics are clinically validated applications / software / online programs that have demonstrated the capability to facilitate positive outcomes when used in the prevention / treatment / management of diseases / clinical conditions. These therapeutics are designed to engage patients in personalized treatment or disease prevention programs, through mediating behavioral or psychological modifications, providing motivational support and inculcating healthy lifestyle changes.
Leading Digital Therapeutics Companies
Examples of key players engaged in digital therapeutics market (which have also been profiled in this report) include (in alphabetical order) Ampersand Health, Akili Interactives, Better Therapeutics, Brain+, Click Therapeutics, CogniFit, GAIA, Healios, JOGO Health, Jolly Good, KORE Digital Health Therapeutics, Livongo Health, Lucid, MedRhythms, Pear Therapeutics, Redicare Control, Susmed, The Learning Corp, Voluntis and WellDoc.
Distribution by Type of Solution - Software Solution, Gaming Solution and Combination Solution
Distribution by Type of Therapy - Curative and Preventive
Distribution by Purpose of Solution - Medication Replacement and
Medication Augmentation
Distribution by Type of Business Model - B2B and B2C
Distribution by Target Therapeutic Area - Cardiovascular Disorders, Chronic Pain, Mental Health Problems, Metabolic Disorders, Neurological Disorders Respiratory Disorders, Sleep Disorders, Substance use Disorders and Other Disorder
Key Geographical Regions - North America, Europe, Asia, Latin America, Middle East and North Africa, and Rest of the World.
Digital therapeutics market - Current market landscape
We came across several industry players that are presently engaged in the development of digital therapeutic solutions. The domain is currently dominated by small-sized and very small-sized players . This can be attributed to the fact that healthcare domain has seen a shift from traditional medicines to digital solutions in the recent years, especially with increase in cases where the patients are not able to frequently visit their healthcare professional. In fact, in the recent years, a number of digital therapeutics have received regulatory approval, which has spurred the establishment of many start-ups in this domain.
Even though efforts for development of digital therapeutic solutions have been undertaken by players based all across the globe, majority of the developers are headquartered in North America. It is worth mentioning that within North America, maximum number of players are headquartered in the US . Similarly, within Europe, more than players are based in UK, France, Germany and Switzerland. Further, Australia, Israel, Japan and South Korea are major hubs in Asia-Pacific regions.
We were able to identify 415 digital therapeutic solutions that are either marketed or under development for providing curative / preventive therapy for a range of clinical conditions. It is worth mentioning that majority (46%) of the solutions that have been / are being developed are standalone software applications, followed by solutions including combination of software application and personal coach (14%), software application, device and personal coach, software application and device, and gaming solution and device.
Currently, more than to 220 digital therapeutic solutions have already been developed. Of these, majority of the solution have been marketed, followed by solutions that have been approved by regulatory bodies. In addition, majority of the solutions (86%) have been / are being developed targeting old patient populations.
It is worth mentioning that majority of the digital therapeutic solutions are being / have been developed for treating diabetes and anxieties, 13% each. In addition, we were able to identify 10% solutions that target depression.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/digital-ther
